【结 构 式】 |
【分子编号】23310 【品名】tert-butyl (2R)-2-(hydroxymethyl)-1-pyrrolidinecarboxylate 【CA登记号】 |
【 分 子 式 】C10H19NO3 【 分 子 量 】201.2658 【元素组成】C 59.68% H 9.52% N 6.96% O 23.85% |
合成路线1
该中间体在本合成路线中的序号:(II)Treatment of (R)-2-pyrrolidine methanol (I) with di-tert-butyl dicarbonate and K2CO3 gave carbamate (II), which was converted to mesylate (III) using methanesulfonyl chloride and Et3N. Subsequent reaction of (III) with NaCN in DMF provided nitrile (IV). The catalytic hydrogenation of this nitrile in the presence of 4-methylpiperidine (V) furnished the (piperidinylethyl)pyrrolidine (VI). After Boc deprotection of (VI) with trifluoroacetic acid in refluxing CH2Cl2, the resulting pyrrolidine (VII) was finally condensed with m-toluenesulfonyl chloride (VIII) to give the target sulfonamide.
【1】 King, F.D.; Forbes, I.T.; Rahman, S.K. (SmithKline Beecham plc); Sulphonamide derivs. and their use in the treatment of CNS disorders. WO 9748681 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 23309 | (2R)pyrrolidinylmethanol | 68832-13-3 | C5H11NO | 详情 | 详情 |
(II) | 23310 | tert-butyl (2R)-2-(hydroxymethyl)-1-pyrrolidinecarboxylate | C10H19NO3 | 详情 | 详情 | |
(III) | 23311 | tert-butyl (2R)-2-[[(methylsulfonyl)oxy]methyl]-1-pyrrolidinecarboxylate | C11H21NO5S | 详情 | 详情 | |
(IV) | 23312 | tert-butyl (2R)-2-(cyanomethyl)-1-pyrrolidinecarboxylate | C11H18N2O2 | 详情 | 详情 | |
(V) | 10192 | 4-Methylpiperidine; gamma-Pipecoline | 626-58-4 | C6H13N | 详情 | 详情 |
(VI) | 23314 | tert-butyl (2R)-2-[2-(4-methyl-1-piperidinyl)ethyl]-1-pyrrolidinecarboxylate | C17H32N2O2 | 详情 | 详情 | |
(VII) | 23315 | 4-methyl-1-[2-[(2R)pyrrolidinyl]ethyl]piperidine | C12H24N2 | 详情 | 详情 | |
(VIII) | 23316 | 3-methylbenzenesulfonyl chloride | 1899-93-0 | C7H7ClO2S | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(I)Oxidation of N-Boc-D-prolinol (I) with pyridinium dichromate affords aldehyde (II). This is subjected to Wittig condensation with methylene triphenylphosphorane to furnish N-Boc-2-vinylpyrrolidine (III). Hydroboration of (III) with 9-borabicyclononane, followed by oxidative work-up, leads to the primary alcohol (IV). Subsequent acidic Boc group cleavage in (IV) provides 2-pyrrolidinyl ethanol (V). Acylation of amine (V) with 4-methyl-3-nitrobenzenesulfonyl chloride (VI) gives sulfonamide (VII). The hydroxyl group of (VII) is further protected with methoxymethyl chloride, producing the methoxymethyl ether (VIII). Conversion of the ortho-nitrotoluene system (VIII) into indole (X) is then accomplished according to the Leimgruber-Batcho procedure, by condensation of (VIII) with dimethylformamide dimethylacetal, followed by reduction of the resultant nitro enamine (IX) with hydrazine in the presence of Raney nickel. Protection of the indole N of (X) with benzenesulfonyl chloride and NaH affords sulfonamide (XI). After acidic hydrolysis of the methoxymethyl protecting group of (XI), the N-phenylsulfonyl group is removed under alkaline conditions to yield indole (XII)
【1】 Forbes, I.T.; Gribble, A.D. (GlaxoSmithKline plc); Sulfonamide cpds., their preparation and use. WO 0262788 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 23310 | tert-butyl (2R)-2-(hydroxymethyl)-1-pyrrolidinecarboxylate | C10H19NO3 | 详情 | 详情 | |
(II) | 60087 | tert-butyl (2R)-2-formyl-1-pyrrolidinecarboxylate | C10H17NO3 | 详情 | 详情 | |
(III) | 60088 | tert-butyl (2R)-2-vinyl-1-pyrrolidinecarboxylate | C11H19NO2 | 详情 | 详情 | |
(IV) | 60089 | tert-butyl (2R)-2-(2-hydroxyethyl)-1-pyrrolidinecarboxylate | C11H21NO3 | 详情 | 详情 | |
(V) | 60090 | 2-[(2R)pyrrolidinyl]-1-ethanol | C6H13NO | 详情 | 详情 | |
(VI) | 60091 | 4-methyl-3-nitrobenzenesulfonyl chloride | C7H6ClNO4S | 详情 | 详情 | |
(VII) | 60092 | 2-{(2R)-1-[(4-methyl-3-nitrophenyl)sulfonyl]pyrrolidinyl}-1-ethanol | C13H18N2O5S | 详情 | 详情 | |
(VIII) | 60093 | methoxymethyl 2-{(2R)-1-[(4-methyl-3-nitrophenyl)sulfonyl]pyrrolidinyl}ethyl ether; (2R)-2-[2-(methoxymethoxy)ethyl]-1-[(4-methyl-3-nitrophenyl)sulfonyl]pyrrolidine | C15H22N2O6S | 详情 | 详情 | |
(IX) | 60094 | (E)-2-[4-({(2R)-2-[2-(methoxymethoxy)ethyl]pyrrolidinyl}sulfonyl)-2-nitrophenyl]-N,N-dimethyl-1-ethenamine; N-{(E)-2-[4-({(2R)-2-[2-(methoxymethoxy)ethyl]pyrrolidinyl}sulfonyl)-2-nitrophenyl]ethenyl}-N,N-dimethylamine | C18H27N3O6S | 详情 | 详情 | |
(X) | 60095 | 6-({(2R)-2-[2-(methoxymethoxy)ethyl]pyrrolidinyl}sulfonyl)-1H-indole; {2-[(2R)-1-(1H-indol-6-ylsulfonyl)pyrrolidinyl]ethoxy}methyl methyl ether | C16H22N2O4S | 详情 | 详情 | |
(XI) | 60096 | 6-({(2R)-2-[2-(methoxymethoxy)ethyl]pyrrolidinyl}sulfonyl)-1-(phenylsulfonyl)-1H-indole; methoxymethyl 2-((2R)-1-{[1-(phenylsulfonyl)-1H-indol-6-yl]sulfonyl}pyrrolidinyl)ethyl ether | C22H26N2O6S2 | 详情 | 详情 | |
(XII) | 60097 | 2-[(2R)-1-(1H-indol-6-ylsulfonyl)pyrrolidinyl]-1-ethanol | C14H18N2O3S | 详情 | 详情 |